Please join Human Services Center Corporation in honoring National Women and Girls HIV/AIDS Awareness Day on Tuesday, March 9 at 5:00PM via Zoom. We will discuss women’s sexual health, women and HIV, and healthy living with HIV. RSVP here. If you have questions, please contact email@example.com or 412-436-9537.
Here’s a friendly reminder for the HIV community: The HHS Office of Infectious Disease and HIV/AIDS Policy (OIDP) invites you to join us on January 27, 2021, for a stakeholder webinar on efforts to implement the Ending the HIV Epidemic: A Plan for America (EHE) initiative. The EHE Stakeholder webinar will be held from 2:00 to 3:30 p.m. (ET).
This webinar is designed to:
- Provide updates on major federal activities related to the implementation of the Ending the HIV Epidemic initiative
- Highlight ways to improve HIV diagnosis, care and prevention outcomes for Black Women
- Opportunity for question and answer from major stakeholders with federal officials
Wednesday, January 27th, 2021
2:00 – 3:30 pm (ET)
Click here to register.
Registration is required for the webinar. This event is open to everyone, please note capacity is limited so register early! This webinar will be audio-recorded and slides will be publicly available for those unable to attend.
From the World Health Organization (WHO)…
On 1 December WHO joins partners in paying tribute to all those working to provide HIV services, and in calling on global leaders and citizens to rally for “global solidarity” to maintain essential HIV services during COVID 19 and beyond. It is a call to focus on vulnerable groups who are already at risk and expand coverage to children and adolescents. And in 2020, the International Year of the Nurse and the Midwife, it is a call for more protection and support to these health workers who have long been on the frontline of HIV service delivery. We can all contribute to the effort to end AIDS and make the world a healthier place.
Find out more on the WHO Website.
The HIV Prevention and Care Project at the University of Pittsburgh–on behalf of the Pennsylvania HIV Planning Group–is hosting two COVID-19 and HIV Virtual Listening Sessions. These two sessions will provide a space for people living with HIV in Pennsylvania to share their concerns about COVID-19 and its life-disrupting effects.
Session 1 will take place on October 14th from 4:00-5:30 pm for the Northwest, Northcentral, and Southwest regions of Pennsylvania.
Session 2 will take place on October 21st from 4:00-5:30 pm for the Southcentral, Northeast, and Eastcentral (AIDSNET) regions.
Participants are required to preregister in order to receive a link to the virtual meeting. To register and find out more about session 1, click here. To register and find out more about session 2, click here.
A message from HIV.gov and ADM Brett Giroir, MD, Assistant Secretary for Health, U.S. Department of Health and Human Services…
In the 25 years since National HIV Testing Day (NHTD) was first observed on June 27th, we’ve made remarkable progress on HIV prevention, treatment, and research—but people who haven’t been tested will not know their status or how to benefit from prevention tools or HIV medications.
So the theme for this year’s observance—“Knowing”—is particularly important. It means:
- Knowing your testing options (including self-testing)
- Knowing your risk
- Knowing your prevention options (including Ready, Set, PrEP)
- Knowing about treatment options
- Knowing the importance of achieving and maintaining viral suppression
- Knowing that together we can end the HIV epidemic
I invite you to watch this message from ADM Brett Giroir, MD, Assistant Secretary for Health, U.S. Department of Health and Human Services, about these important aspects of Knowing.
The only way to know your HIV status is to get tested—and taking that test is a key step down the path toward ending the HIV epidemic in the United States.
That’s the path we are walking with the Ending the HIV Epidemic: A Plan for America (EHE) initiative, which aims to achieve epidemic control in our nation within 10 years. How? By decreasing the number of new HIV transmissions by at least 90% by 2030. The first pillar of EHE is to diagnose all people with HIV as early as possible.
Read more on HIV.gov.
The conference is the largest national meeting for HIV care and treatment providers, Ryan White HIV/AIDS Program recipients, and other stakeholders. This year’s theme is “30 Years of Innovating Care, Optimizing Public Health, Ending the HIV Epidemic,” which is timely as HRSA recognizes a major program milestone, 30 years since the Ryan White Comprehensive AIDS Resources Emergency (CARE) Act was first enacted.
The National Ryan White Conference is held every two years to deliver program and policy updates, share best practices and innovative models of care, and provide technical assistance to Ryan White HIV/AIDS Program recipients and subrecipients.
To register for the conference, visit ryanwhiteconference.hrsa.gov.
Registrants will receive information on booking a hotel room once your registration is approved.
Advances in HIV prevention and program implementation were among the topics in the spotlight at the 22nd International AIDS Conference (AIDS 2018) this week. Eugene McCray, MD, Director of CDC’s Division of HIV/AIDS Prevention (DHAP)
reflects on some of the conference highlights. The division he oversees works to prevent HIV infections and reduce the incidence of HIV-related illness and death across the United States. Read more about their work.
During a live interview on Facebook, Dr. McCray discussed research being presented by CDC researchers at the conference, other HIV prevention research findings shared here at the conference, and shares his personal reflection on what how it feels like to be at this conference at this stage of the epidemic.
The first full day of sessions at the 22nd International AIDS Conference (AIDS 2018) in Amsterdam was filled with new scientific findings shared by researchers from around the world. In a Facebook Live interview with HIV.gov, Carl Dieffenbach, Ph.D., discussed highlights of three studies presented today at the conference, including:
- an update on a potential association between the HIV treatment medication dolutegravir and birth defects;
- additional research on the effectiveness of HIV treatment as prevention among gay male serodifferent couples; and
- a study on whether there may be drug-drug interactions between PrEP and feminizing hormone therapy for transgender women.
Dr. Dieffenbach is the Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID).
As the 22nd International AIDS Conference (AIDS 2018) got underway in Amsterdam, HIV.gov began their coverage of HIV research advances and other conference highlights with an interview of Anthony S. Fauci, M.D. Dr. Fauci is the Director of the National Institute of Allergy and Infectious Diseases at the NIH.
The International AIDS Conference is the largest conference on any global health issue in the world. First convened during the peak of the AIDS epidemic in 1985, it continues to provide a unique forum for the intersection of science, advocacy, and human rights. According to its organizers, each conference is an opportunity to strengthen policies and programs that ensure an evidence-based response to the epidemic.
The theme of AIDS 2018 is “Breaking Barriers, Building Bridges,” drawing attention to the need of rights-based approaches to more effectively reach key populations. AIDS 2018 aims to promote human rights based and evidence-informed HIV responses that are tailored to the needs of particularly vulnerable communities – including people living with HIV, displaced populations, men who have sex with men, people in prisons and other closed settings, people who use drugs, sex workers, transgender people, women and girls and young people – and collaborate in fighting the disease beyond country borders.